5.39 USD
↗ 0.31 (6.10%)AT CLOSE (11:59 AM EDT)
Aquestive Therapeutics, Inc. Common Stock
AQSTNASDAQ • USD
5.31
↘ 0.08 (1.50%)
POST MARKET (AS OF 07:39 PM EDT)
Post Market
AS OF 07:39 PM EDT
5.31
↘ 0.08 (1.50%)
Market: OPEN
Shares of Aquestive Therapeutics, Inc. Common Stock (AQST) are trading at $5.31. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (138.2%) and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$5.08
High?$5.41
Low?$5.01
Prev. Close?$5.08
Volume?3.4M
Avg. Volume?3.2M
VWAP?$5.27
Rel. Volume?1.07x
Bid / Ask
Bid?$4.60 × 100
Ask?$6.09 × 100
Spread?$1.49
Midpoint?$5.35
Valuation & Ratios
Market Cap?637.6M
Shares Out?125.5M
Float?100.0M
Float %?81.9%
P/E Ratio?N/A
P/B Ratio?-11.27
EPS?-$0.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
Employees
147
Market Cap
637.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2018-07-25
Address
30 TECHNOLOGY DRIVE
WARREN, NJ 07059
Phone: 908-941-1900
WARREN, NJ 07059
Phone: 908-941-1900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?73
Short Sent.?21
Piotroski F-Score?4/9Mixed
Altman Z-Score?-3.09Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?20.96%Squeeze Risk
Short Interest?21.0M
Days to Cover?5.2
Free Float100.0M
Avg Daily Volume4.0M
Settlement Date2026-08-14
Financial Health
Current Ratio?7.19Strong
Quick Ratio?6.74Strong
Cash Ratio?5.98Strong
Debt/Equity?-0.90Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-11.27CHEAP▾
S&P97
P/S?11.79HIGH▾
Peers100
S&P6
P/FCF?N/A▾
EV/EBITDA?-10.7CHEAP▾
S&P97
EV/Sales?10.90HIGH▾
Peers100
S&P9
Returns & Efficiency
ROE?138.2%STRONG▾
Peers50
S&P97
ROA?-59.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-45949000
Enterprise Value?$589.8M
Fundamentals ratios updated end of day